Developer docs
API playgroundTry for free, no card

Search company profiles

Quantib

Full company profile

uuid0002wcd

Namestring
Quantib
Legal namestring
Quantib BV
Websiteurl
quantib.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Quantib BV is a Netherlands-based healthcare AI company that develops machine learning software for the automated analysis of medical imaging data, primarily MRI and CT scans. Founded in 2013 as a spin-off of Erasmus MC in Rotterdam, the company built a portfolio of FDA-cleared and CE-marked products, including Quantib Prostate for AI-assisted prostate cancer detection compatible with leading fusion biopsy systems, and Quantib ND / Quantib Brain for brain atrophy quantification and white matter hyperintensities detection in neurodegenerative disease assessment. The underlying technology applies advanced computer vision and anomaly detection techniques to detect tissue changes earlier than manual visual review, shortening diagnosis workflows and improving objectivity for radiologists. Distribution historically ran through direct enterprise sales to healthcare institutions and radiology departments across Europe and the United States.

In 2022, Quantib was acquired by RadNet, Inc. (NASDAQ: RDNT), a major US outpatient diagnostic imaging provider, and in 2023 was integrated into DeepHealth, RadNet's AI-powered health informatics portfolio. Under DeepHealth, the original Quantib products have been rebranded as DeepHealth Prostate and DeepHealth Brain and are sold alongside a broader suite of enterprise imaging (Diagnostic Suite, Operations Suite, TechLive) and population health (Breast, Chest, Neuro, Thyroid) solutions. Quantib BV continues to manufacture the prostate and brain products for DeepHealth Inc., operating as a wholly-owned subsidiary under RadNet's ownership. Revenue model and pricing are not publicly disclosed, but the product is positioned as a regulated medical device sold to enterprise healthcare buyers globally.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRotterdam, Netherlands
HQ citystring
Rotterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
medical imaging AI, prostate cancer detection, neurodegenerative imaging, radiology software, brain MRI analysis
Industry3 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Radiology AI Software
Social media profiles2 records
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Quantib Prostate
Description

AI-powered prostate cancer detection solution, now integrated into DeepHealth Prostate

deephealth.com
+2 more records
Core offering1 text field

Quantib develops AI-powered medical imaging analysis software that automatically analyzes MRI and other diagnostic scans to detect tissue changes earlier than visual inspection. Its products focus on prostate cancer detection (Quantib Prostate, now DeepHealth Prostate) and neurodegenerative disease assessment including brain atrophy quantification and white matter hyperintensities detection (Quantib ND/Brain, now DeepHealth Brain). The software is FDA-cleared and CE-marked for clinical use.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Quantib, now integrated into DeepHealth, was a platform of AI-powered medical imaging analysis solutions. The original product portfolio included Quantib Prostate, Quantib ND, and Quantib Brain, which have been rebranded as DeepHealth Prostate and DeepHealth Brain under the DeepHealth umbrella. DeepHealth operates as a unified AI-powered health informatics platform with Enterprise Imaging products (Diagnostic Suite™, Operations Suite™, TechLive™) and Population Health solutions (Breast Suite, Prostate Suite, Chest Suite, Neuro Suite, Thyroid Suite). Quantib's core technology used advanced machine learning for automatic analysis of medical imaging data, particularly MRI scans, enabling earlier tissue change detection than manual review.

Product and service3 records
1Quantib Prostate (DeepHealth Prostate)
CategoryProstate Cancer Detection Software
Description

AI-powered prostate cancer detection solution compatible with leading fusion biopsy systems. End-to-end AI-powered solution that streamlines workflow integration, automates mundane tasks, and decreases clicks for radiologists.

2Quantib Brain (DeepHealth Brain)
CategoryNeurodegenerative Disease Imaging Software
Description

AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection. Assesses and monitors neurodegenerative changes with quantitative and reference data for radiologists and neurologists.

3Quantib ND
CategoryNeurodegenerative Disease Imaging Software
Description

Neurodegenerative disease assessment solution for brain imaging analysis, providing population health tools for assessing and monitoring neurodegenerative changes.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quantib

Radiology AI Softwarequantib.com

What Quantib does

Quantib BV is a Netherlands-based healthcare AI company that develops machine learning software for the automated analysis of medical imaging data, primarily MRI and CT scans. Founded in 2013 as a spin-off of Erasmus MC in Rotterdam, the company built a portfolio of FDA-cleared and CE-marked products, including Quantib Prostate for AI-assisted prostate cancer detection compatible with leading fusion biopsy systems, and Quantib ND / Quantib Brain for brain atrophy quantification and white matter hyperintensities detection in neurodegenerative disease assessment. The underlying technology applies advanced computer vision and anomaly detection techniques to detect tissue changes earlier than manual visual review, shortening diagnosis workflows and improving objectivity for radiologists. Distribution historically ran through direct enterprise sales to healthcare institutions and radiology departments across Europe and the United States.

In 2022, Quantib was acquired by RadNet, Inc. (NASDAQ: RDNT), a major US outpatient diagnostic imaging provider, and in 2023 was integrated into DeepHealth, RadNet's AI-powered health informatics portfolio. Under DeepHealth, the original Quantib products have been rebranded as DeepHealth Prostate and DeepHealth Brain and are sold alongside a broader suite of enterprise imaging (Diagnostic Suite, Operations Suite, TechLive) and population health (Breast, Chest, Neuro, Thyroid) solutions. Quantib BV continues to manufacture the prostate and brain products for DeepHealth Inc., operating as a wholly-owned subsidiary under RadNet's ownership. Revenue model and pricing are not publicly disclosed, but the product is positioned as a regulated medical device sold to enterprise healthcare buyers globally.

Quantib firmographics

Firmographics
Name
Quantib
Legal name
Quantib BV
Website
https://quantib.com
Company type
Private
Founded year
2013
Operating status
Acquired
Headcount range
1–10 employees
Ownership category
akta.pro rank

Quantib industry classification

Industry
Product category
Radiology AI Software
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Medical imaging AI
  • Prostate cancer detection
  • Neurodegenerative imaging
  • Radiology software
  • Brain MRI analysis

Where Quantib is headquartered

Location

Headquarters

HQ city
Rotterdam
HQ country
Netherlands
HQ region
Europe

Markets served

Quantib business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Quantib product offering

Product offering

Core offering

Quantib develops AI-powered medical imaging analysis software that automatically analyzes MRI and other diagnostic scans to detect tissue changes earlier than visual inspection. Its products focus on prostate cancer detection (Quantib Prostate, now DeepHealth Prostate) and neurodegenerative disease assessment including brain atrophy quantification and white matter hyperintensities detection (Quantib ND/Brain, now DeepHealth Brain). The software is FDA-cleared and CE-marked for clinical use.

Product overview

Quantib, now integrated into DeepHealth, was a platform of AI-powered medical imaging analysis solutions. The original product portfolio included Quantib Prostate, Quantib ND, and Quantib Brain, which have been rebranded as DeepHealth Prostate and DeepHealth Brain under the DeepHealth umbrella. DeepHealth operates as a unified AI-powered health informatics platform with Enterprise Imaging products (Diagnostic Suite™, Operations Suite™, TechLive™) and Population Health solutions (Breast Suite, Prostate Suite, Chest Suite, Neuro Suite, Thyroid Suite). Quantib's core technology used advanced machine learning for automatic analysis of medical imaging data, particularly MRI scans, enabling earlier tissue change detection than manual review.

Differentiator

Problem solved

Functional benefit

Brands

  • Quantib Prostate: AI-powered prostate cancer detection solution, now integrated into DeepHealth Prostate
  • Quantib ND
  • Quantib Brain

Products and services

  • Quantib Prostate (DeepHealth Prostate) AI-powered prostate cancer detection solution compatible with leading fusion biopsy systems. End-to-end AI-powered solution that streamlines workflow integration, automates mundane tasks, and decreases clicks for radiologists.
  • Quantib Brain (DeepHealth Brain) AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection. Assesses and monitors neurodegenerative changes with quantitative and reference data for radiologists and neurologists.
  • Quantib ND Neurodegenerative disease assessment solution for brain imaging analysis, providing population health tools for assessing and monitoring neurodegenerative changes.

Companies that use Quantib

Customer profile

Segments1 record

Ideal customer profiles1 record

Quantib technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Quantib partnerships and signals

Strategic signal

Recent moves7 records

Expansion highlights4 records

Quantib competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Quantib social profiles

Digital presence

Quantib financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quantib leadership team

Management profile

Number of profiles

Profiles3 records

Quantib funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quantib M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quantib

What does Quantib do?

Quantib develops AI-powered medical imaging analysis software that automatically analyzes MRI and other diagnostic scans to detect tissue changes earlier than visual inspection. Its products focus on prostate cancer detection (Quantib Prostate, now DeepHealth Prostate) and neurodegenerative disease assessment including brain atrophy quantification and white matter hyperintensities detection (Quantib ND/Brain, now DeepHealth Brain). The software is FDA-cleared and CE-marked for clinical use.

Is Quantib a public or private company?

Quantib is a private company. It is classified as corporate owned and is currently acquired.

When was Quantib founded?

Quantib was founded in 2013. It employs 1 to 10 people.

Where is Quantib based?

Quantib is headquartered in Rotterdam, Netherlands, in the Europe region.

Does Quantib have an API?

No public API is recorded for Quantib.

What industry is Quantib in?

Quantib's product category is Radiology AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comGlobal Neuroimaging Software Market Size, Share and Forecast By Key Players-IXICO,QMENTA,Cortechs.ai,Quantib,BrainomixThe global neuroimaging software market is projected to grow from $9.62 billion in 2024 to $20.02 billion by 2031, a CAGR of 12.99%. Growth is driven by demand for brain imaging in diagnostics and research, with Asia-Pacific expected to be the fastest-growing region.GlobeNewswireRadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 SoftwareRadNet's Quantib B.V. subsidiary received FDA clearance for Quantib Prostate 3.0, an AI software for prostate MRI reading. The software includes AI-based segmentations, volumetry, PSA density calculation, and PI-RADS scoring support. An upcoming release will add improved segmentation and automated lesion drawing.GlobeNewswireRadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI ToolsRadNet's subsidiaries DeepHealth and Quantib received FDA clearances for their AI mammography and prostate MRI tools. Saige-DX improves breast cancer detection with lower false positives, while Quantib Prostate 2.0 adds automatic zone segmentation. The approvals aim to improve patient outcomes and reduce costs.GlobeNewswireRadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI ToolsRadNet's subsidiaries DeepHealth and Quantib received FDA clearances for their AI mammography and prostate MRI tools. Saige-DX improves breast cancer detection with lower false positives, while Quantib Prostate 2.0 adds automatic zone segmentation. The approvals aim to improve patient outcomes and reduce costs.GlobeNewswireRadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial IntelligenceRadNet completed acquisitions of Aidence and Quantib, adding AI tools for lung and prostate cancer screening. Aidence's lung nodule detection is pending FDA clearance, while Quantib's prostate MRI solution has FDA 510(k) clearance. The companies will join RadNet's AI division to expand screening offerings.GlobeNewswireRadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial IntelligenceRadNet acquired Dutch AI companies Aidence and Quantib to expand its AI portfolio for lung and prostate cancer screening. Aidence's lung nodule detection product is pending FDA clearance, while Quantib's prostate and brain MRI solutions have FDA 510(k) clearance. The acquisitions aim to enable large-scale screening programs for the three most prevalent cancers.Aidoc5 Ways AI Can Assist Radiologists- Healthcare AIThe article outlines how artificial intelligence can augment radiologists' workflows by improving accuracy, prioritizing urgent cases, and automating routine tasks to address staff shortages and burnout. It highlights specific AI vendors such as Aidoc, Icometrix, and Quantib that provide these decision-support solutions in the medical imaging sector. The piece argues that AI serves as a productivity tool rather than a replacement for human professionals, citing data from Gartner on potential efficiency gains.StartupJunctureAI analytics startup Quantib raises €4.5M for better diagnosesRotterdam-based AI startup Quantib raised €4.5M in a round led by Holland Venture and InnovationQuarter. The funding will support new machine learning medical imaging applications and international expansion. The company's first product, for neurological disorders, received FDA approval and CE marking in 2016.